InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
13%
T+90 mean return
-23.3%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Cohen Chad M, Chief Financial Officer. Insider active across 3 companies, notably Adaptive Biotechnologies Corp. Cumulatively, 16 reports have been logged. History available since 11 May 2021. The latest transaction was filed on 2 June 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations16 total
13,593 shares0Common StockSEC:0001524314-26-000001:0
4,049 shares0Common StockSEC:0001524314-26-000001:1
9,336 shares0Common StockSEC:0001415889-25-020856:0
1,397 shares0Common StockSEC:0001415889-25-015819:0
8,158 sharesClass A Common StockSEC:0001140361-25-016925:0
20,134 shares0Class A Common StockSEC:0001874944-24-000062:0
170,940 shares0Class A Common StockSEC:0001874944-23-000053:0
33,999 shares0Class A Common StockSEC:0001874944-22-000028:0
10,000 shares@ US$7.270.0031% mcap8.7% of flowCommon StockSEC:0001209191-21-071193:0
5,000 shares@ US$7.270.0015% mcap4.2% of flowCommon StockSEC:0001209191-21-064253:0
5,000 shares@ US$7.270.0015% mcap4.2% of flowCommon StockSEC:0001209191-21-059985:0
9,375 shares@ US$6.550.0025% mcap7.0% of flowCommon StockSEC:0001209191-21-055368:0
5,000 shares@ US$6.550.0014% mcap3.8% of flowCommon StockSEC:0001209191-21-051275:0
10,000 shares@ US$6.550.0027% mcap7.5% of flowCommon StockSEC:0001209191-21-046082:0
10,000 shares@ US$6.550.0026% mcap7.3% of flowCommon StockSEC:0001209191-21-039637:0
10,000 shares@ US$6.550.0026% mcap7.3% of flowCommon StockSEC:0001209191-21-032438:0
16 of 16 declarations
About Cohen Chad M
Chad M Cohen is an executive at Adaptive Biotechnologies Corp.
